FDA approves once-weekly dosing for Amgen’s Kyprolis in multiple myeloma treatment

The United States Food and Drug Administration (FDA) has granted approval for a new once-weekly dosing regimen of Amgen's Kyprolis (carfilzomib) in combination with dexamethasone ... Read More